Group 1 - The A-share electronic chemical industry concept experienced a volatile rise in early trading, with Guangxin Materials increasing by over 14% [1] - Other stocks such as Huat Electric, Hongchang Electronics, Qiangli New Materials, and Feikai Materials also saw gains [1] - A cross-strait electronic chemical industry cooperation meeting was recently held, resulting in the signing of 18 projects with a total investment of 6.257 billion yuan [1]

Core Viewpoint - The company is providing guarantees for its wholly-owned subsidiary Zhuhai Hongchang and its wholly-owned grandchild company Zhuhai Hongren to secure bank financing, totaling up to RMB 2 billion for the current guarantee and a cumulative guarantee amount of RMB 17.35 billion as of the announcement date [2][3][17]. Summary by Sections Guarantee Overview - The company approved a total guarantee amount of up to RMB 2.2 billion for its subsidiaries, with specific allocations of RMB 1.63 billion for Zhuhai Hongchang and RMB 570 million for Zhuhai Hongren [3]. - The guarantees were approved in the board meeting on April 22, 2025, and subsequently ratified in the annual shareholders' meeting on May 14, 2025 [3][16]. Progress of Guarantees - The company has signed guarantee contracts with various banks, including: - RMB 50 million with Dongguan Rural Commercial Bank for Zhuhai Hongchang [4]. - RMB 35 million with China Trust Commercial Bank for Zhuhai Hongchang [4]. - RMB 200 million with China Minsheng Bank for Zhuhai Hongren [7]. - The cumulative guarantee amount for Zhuhai Hongchang is RMB 1.355 billion, and for Zhuhai Hongren is RMB 380 million, totaling RMB 17.35 billion for both subsidiaries [5][7]. Basic Information of the Guaranteed Companies - **Zhuhai Hongchang**: - Established on September 8, 2008, with a registered capital of USD 12.39 million. - As of December 31, 2024, total assets were approximately RMB 2.13 billion, total liabilities were about RMB 1.4 billion, and net profit was RMB 23.56 million [8][9]. - **Zhuhai Hongren**: - Established on May 24, 2022, with a registered capital of RMB 385 million. - As of December 31, 2024, total assets were approximately RMB 311 million, total liabilities were about RMB 42.57 million, with a net loss of RMB 838,401.98 [11]. Necessity and Reasonableness of Guarantees - The guarantees are aimed at meeting the financing needs for project construction and daily operations of the subsidiaries, enhancing their financing capabilities [15]. - The company maintains effective management over the subsidiaries, allowing for timely oversight of their credit status, ensuring that the guarantee risks are controllable and do not harm the interests of the company or minority shareholders [15]. Board Opinion - The board unanimously approved the guarantee proposal, emphasizing the necessity to support the subsidiaries' project needs and confirming the controllable nature of the guarantee risks [16].

证券代码:603002 证券简称:宏昌电子 公告编号:2025-028 宏昌电子材料股份有限公司 关于为全资子公司珠海宏昌、全资孙公司珠海宏仁向 银行申请融资额度提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 一、担保情况概述 公司于 2025 年 4 月 22 日召开第六届董事会第十四次会议通过了《关于为全 资子公司、全资孙公司向银行申请融资额度提供担保的议案》，同意公司为全资 被担保人名称：珠海宏昌电子材料有限公司（以下简称"珠海宏昌"）， 为宏昌电子材料股份有限公司（以下简称"公司"）全资子公司；珠海 宏仁电子材料科技有限公司（以下简称"珠海宏仁"），为公司全资孙 公司 本次担保金额及已实际为其提供的担保余额： 1、本次增加为珠海宏昌提供担保金额为人民币 0.85 亿元，累计为其担保金 额为等值人民币 13.55 亿元（含本次担保）； 2、本次增加为珠海宏仁提供担保金额为人民币 2.00 亿元，累计为其担保金 额为等值人民币 3.80 亿元（含本次担保）； 3、截至本公告日，累计 ...

Group 1 - The company approved a capital increase of $28 million to its subsidiary Zhuhai Hongchang Electronic Materials Co., Ltd. on May 7, 2025 [1] - The company’s board of directors held a meeting on May 26, 2025, to approve an additional capital increase of $10 million from its wholly-owned subsidiary Hong Kong Hongchang to Zhuhai Hongchang [2] - Following the approval, Zhuhai Hongchang completed the registration change on June 6, 2025, increasing its registered capital from $85.9 million to $123.9 million [2]

证券代码：603002 证券简称：宏昌电子 公告编号：2025-027 宏昌电子材料股份有限公司 关于子公司珠海宏昌电子材料有限公司 完成工商登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 为谋求长远发展，宏昌电子材料股份有限公司（以下简称"公司"或"宏昌 电子"）于 2025 年 5 月 7 日召开第六届董事会第十六次会议审议通过《关于向 子公司珠海宏昌电子材料有限公司增资的议案》，同意公司向子公司珠海宏昌电 子材料有限公司（以下简称"珠海宏昌"）增加注册资本 2,800 万美元，以上增 资款由公司全额认缴（具体请见公司 2025 年 5 月 8 日于上海证券交易所网站披 露 2025-021 号公告）。 为进一步增强珠海宏昌资金实力，公司于 2025 年 5 月 26 日召开第六届董事 会第十七次会议审议通过《关于全资子公司香港宏昌向子公司珠海宏昌电子材料 有限公司增资的议案》，同意全资子公司香港宏昌同步向子公司珠海宏昌增加注 册资本 1,000 万美元，以上增资款由香港宏昌全额认缴（具体请见公司 202 ...

Core Viewpoint - The company has announced a profit distribution plan for the fiscal year 2024, which includes a cash dividend of 0.02 RMB per share, totaling approximately 22.68 million RMB to be distributed among shareholders [1][3]. Distribution Plan - The profit distribution plan was approved at the annual shareholders' meeting on May 14, 2025 [1]. - The total number of shares for the distribution is 1,134,078,509 [1]. - The cash dividend will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the registration date [1]. Implementation Details - The cash dividends for unrestricted circulating shares will be distributed through the clearing system of the China Securities Depository and Clearing Corporation [1]. - Shareholders who have completed designated transactions can receive their cash dividends on the payment date at their designated securities business department [1]. Taxation Information - For individual shareholders holding unrestricted circulating shares for over one year, the cash dividend is exempt from personal income tax, resulting in a net distribution of 0.02 RMB per share [4]. - For individual shareholders holding shares for one year or less, the company will not withhold personal income tax at the time of distribution, but tax will be calculated upon the transfer of shares [4]. - For qualified foreign institutional investors (QFII), a 10% withholding tax will apply, resulting in a net cash dividend of 0.018 RMB per share [5][6]. Additional Information - The company will not issue bonus shares or increase capital through this distribution [2]. - The company has provided contact information for inquiries regarding the announcement [7][8].

Summary of Key Points Core Viewpoint - Hongchang Electronics (603002) has shown a positive stock performance with a closing price of 5.76 yuan as of June 6, 2025, reflecting a 2.67% increase from the previous week [1]. Company Announcements - The company announced a cash dividend of 0.02 yuan per share, with the A-share registration date set for June 12, 2025, and both the ex-dividend date and cash dividend payment date on June 13, 2025 [1]. - The profit distribution plan was approved at the annual shareholders' meeting on May 14, 2025, with a total cash dividend payout of 22,681,570.18 yuan based on a total share capital of 1,134,078,509 shares [1]. - Tax implications for shareholders include exemptions for individual shareholders and securities investment funds holding shares for over one year, while QFII investors will have a 10% withholding tax applied [1].

证券代码：603002 证券简称：宏昌电子 公告编号：2025-026 宏昌电子材料股份有限公司2024年年度 权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利0.02元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/6/12 | － | 2025/6/13 | 2025/6/13 | 差异化分红送转： 否 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025 年 5 月 14 日的2024年年度股东大会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配以方案实施前的公司总股本1,134,078,509股为基数，每股派发 现金红利0.02元（含税），共计派发 ...

Core Viewpoint - The company plans to increase the registered capital of its subsidiary, Zhuhai Hongchang Electronic Materials Co., Ltd., by a total of $3,800 million, enhancing its financial strength and supporting future business operations [2][3][12]. Investment Overview - The investment target is Zhuhai Hongchang Electronic Materials Co., Ltd., a subsidiary of Hongchang Electronic Materials Co., Ltd. [2] - The total investment amount includes an increase of $2,800 million from the company and an additional $1,000 million from its wholly-owned subsidiary, Hongkong Hongchang [3][4]. - After the capital increase, Zhuhai Hongchang's registered capital will rise from $8,590 million to $12,390 million [4]. Financial Performance of Zhuhai Hongchang - As of December 31, 2024, Zhuhai Hongchang reported total assets of approximately ¥2,130 million, total liabilities of about ¥1,400 million, and a net asset value of around ¥729 million [8]. - For the fiscal year 2024, Zhuhai Hongchang achieved revenue of approximately ¥1,249 million and a net profit of about ¥24 million [8]. - In 2023, the company had total assets of approximately ¥1,796 million, total liabilities of about ¥1,063 million, and a net asset value of around ¥733 million, with revenue of approximately ¥1,379 million and a net profit of about ¥54 million [9]. Board Approval and Decision-Making - The board of directors approved the capital increase in two meetings, with unanimous support [9][12]. - The investment decision falls within the board's authority and does not require shareholder approval [7][12]. Impact on the Company - The capital increase will not affect the company's control over Zhuhai Hongchang and is expected to optimize the asset-liability structure, enhancing financial strength [12]. - The investment is aimed at supporting Zhuhai Hongchang's operational activities and new project investments [12].

Group 1 - Company Sun Energy plans to repurchase shares worth between 100 million to 200 million yuan for cancellation, with a maximum repurchase price of 6.69 yuan per share [1] - Company Runyang Technology intends to invest up to 300 million yuan in Shanghai Fourier Intelligent Technology Co., with a pre-investment valuation of 8 billion yuan [1] - Company Heng Rui Medicine's subsidiary has received approval for clinical trials of SHR-4712 injection for treating advanced solid tumors [2] Group 2 - Company Lianhuan Pharmaceutical plans to increase capital by 60 million yuan for its wholly-owned subsidiary [2] - Company Hongchang Electronics' subsidiary plans to increase capital by 10 million USD for its other subsidiary [2] - Company Sichuan Meifeng intends to repurchase shares worth between 50 million to 70 million yuan for cancellation, with a maximum repurchase price of 10.07 yuan per share [2] Group 3 - Company Lian Micro plans to liquidate and deregister Jiaxing Kangjing Semiconductor Industry Investment Partnership [4] - Company Jiutian Pharmaceutical has received approval for clinical trials of PDX-04 drug for treating acute gout attacks [5] - Company Pingzhi Information has signed a framework agreement with China Telecom for a GPU computing power project worth approximately 246 million yuan [7] Group 4 - Company Jiu Zhi Tang's subsidiary has initiated Phase II clinical trials for new drug YB211 aimed at treating acute bacterial skin infections [8] - Company Fosun Pharma's subsidiary has received orphan drug designation for HLX22 for gastric cancer treatment in the EU [9] - Company Jianyou Co. plans to repurchase shares worth between 20 million to 40 million yuan for employee stock ownership plans [11] Group 5 - Company Zhi Zheng Co. announced the resignation of its vice president due to personal reasons [13] - Company He Mai Co. signed a cooperation agreement for household photovoltaic systems worth 1 billion yuan [14] - Company Jinan Intelligent's subsidiary won a project bid for electric vehicle charging stations, expected to positively impact performance [16] Group 6 - Company Gaotie Electric plans to distribute a cash dividend of 0.012 yuan per share [18] - Company Guyue Longshan plans to distribute a cash dividend of 0.08 yuan per share [18] - Company Yongmaotai's shareholders plan to reduce their holdings by up to 2.66% of the company's shares [19] Group 7 - Company Tian Cheng Technology's subsidiary received a land idle fee notice for 2.1658 million yuan due to project delays [20] - Company Guangri Co. appointed a new vice president and board secretary to enhance governance [21] - Company Design General Institute won multiple major projects totaling approximately 390 million yuan [22] Group 8 - Company Fuxie Environmental signed a significant contract worth 244 million yuan for a sewage treatment project [23] - Company Lujiazui announced the resignation of its vice chairman due to job transfer [24] - Company Three Squirrels' H-share issuance application has been accepted by the CSRC [24] Group 9 - Company Kanghong Pharmaceutical's subsidiary received approval for clinical trials of KH617 for glioblastoma treatment [25] - Company Xin Zhu Co. announced a suspension of trading to plan an asset acquisition from its controlling shareholder [26] - Company Jianxin Co. announced plans for share reductions by several directors and senior management [28]